These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 25866269

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Aptamers: active targeting ligands for cancer diagnosis and therapy.
    Wu X, Chen J, Wu M, Zhao JX.
    Theranostics; 2015; 5(4):322-44. PubMed ID: 25699094
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Aptamer-guided nanomedicines for anticancer drug delivery.
    Alshaer W, Hillaireau H, Fattal E.
    Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H, Qian W, Uckun FM, Wang L, Wang YA, Chen H, Kooby D, Yu Q, Lipowska M, Staley CA, Mao H, Yang L.
    ACS Nano; 2015 Aug 25; 9(8):7976-91. PubMed ID: 26242412
    [Abstract] [Full Text] [Related]

  • 29. Nucleic acid aptamers targeting cell-surface proteins.
    Dua P, Kim S, Lee DK.
    Methods; 2011 Jun 25; 54(2):215-25. PubMed ID: 21300154
    [Abstract] [Full Text] [Related]

  • 30. Chimeric aptamers in cancer cell-targeted drug delivery.
    Kanwar JR, Roy K, Kanwar RK.
    Crit Rev Biochem Mol Biol; 2011 Dec 25; 46(6):459-77. PubMed ID: 21955150
    [Abstract] [Full Text] [Related]

  • 31. Selection and Application of Aptamers and Intramers.
    Avci-Adali M.
    Adv Exp Med Biol; 2016 Dec 25; 917():241-58. PubMed ID: 27236559
    [Abstract] [Full Text] [Related]

  • 32. Cell-specific aptamer-mediated targeted drug delivery.
    Zhou J, Rossi JJ.
    Oligonucleotides; 2011 Feb 25; 21(1):1-10. PubMed ID: 21182455
    [Abstract] [Full Text] [Related]

  • 33. Generating Cell Targeting Aptamers for Nanotheranostics Using Cell-SELEX.
    Lyu Y, Chen G, Shangguan D, Zhang L, Wan S, Wu Y, Zhang H, Duan L, Liu C, You M, Wang J, Tan W.
    Theranostics; 2016 Feb 25; 6(9):1440-52. PubMed ID: 27375791
    [Abstract] [Full Text] [Related]

  • 34. Aptamers as theranostic agents: modifications, serum stability and functionalisation.
    Shigdar S, Macdonald J, O'Connor M, Wang T, Xiang D, Al Shamaileh H, Qiao L, Wei M, Zhou SF, Zhu Y, Kong L, Bhattacharya S, Li C, Duan W.
    Sensors (Basel); 2013 Oct 10; 13(10):13624-37. PubMed ID: 24152925
    [Abstract] [Full Text] [Related]

  • 35. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X, Zhao Q, Qiu L.
    J Control Release; 2013 Oct 28; 171(2):152-62. PubMed ID: 23777885
    [Abstract] [Full Text] [Related]

  • 36. Aptamer-Directed Specific Drug Delivery and Magnetic Resonance Imaging of Renal Carcinoma Cells In Vitro and In Vivo.
    Li J, Wang J, Sun D, Dai Y, Shen J, You J, Han C, Xu K.
    J Biomed Nanotechnol; 2016 Aug 28; 12(8):1604-616. PubMed ID: 29342341
    [Abstract] [Full Text] [Related]

  • 37. Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system.
    Jing P, Cao S, Xiao S, Zhang X, Ke S, Ke F, Yu X, Wang L, Wang S, Luo Y, Zhong Z.
    Cancer Lett; 2016 Dec 28; 383(2):230-242. PubMed ID: 27721020
    [Abstract] [Full Text] [Related]

  • 38. Advances in screening, synthesis, modification, and biomedical applications of peptides and peptide aptamers.
    Liu Y, Lu X, Chen M, Wei Z, Peng G, Yang J, Tang C, Yu P.
    Biofactors; 2024 Dec 28; 50(1):33-57. PubMed ID: 37646383
    [Abstract] [Full Text] [Related]

  • 39. Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.
    Xiang D, Zheng C, Zhou SF, Qiao S, Tran PH, Pu C, Li Y, Kong L, Kouzani AZ, Lin J, Liu K, Li L, Shigdar S, Duan W.
    Theranostics; 2015 Dec 28; 5(10):1083-97. PubMed ID: 26199647
    [Abstract] [Full Text] [Related]

  • 40. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J, Mokhtarzadeh A.
    Curr Drug Deliv; 2018 Dec 28; 15(9):1323-1329. PubMed ID: 30039760
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.